Stem cell–like memory (TSCM) CD8+ T cells are beneficial in antitumor responses, in part due to their ability to self-renew. Khleif and colleagues demonstrate that inhibition of the kinase MEK in CD8+ T cells favors induction of TSCM and superior antitumor responses.
- Vivek Verma
- Nazli Jafarzadeh
- Samir N. Khleif